Management of cutaneous T-Cell lymphoma patients with extracorporeal photopheresis. The hellenic experience

Transfusion and Apheresis Science

Volumn 46, Issue 2, 2012, Pages 189-193

  Siakantaris, Marina P ^a   Tsirigotis, Panagiotis ^b   Stavroyianni, Niki ^c   Argyropoulos, Kimon V ^a   Girkas, Konstantinos ^b   Pappa, Vasiliki ^b   Chondropoulos, Spiros ^b   Papadavid, Evangelia ^b   Sakellari, Ioanna ^c   Anagnostopoulos, Achilles ^c   Antoniou, Christina ^a   Dervenoulas, John ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c Department of Hematology and Bone Marrow Transplantation   (Greece)

Author keywords

Combination treatment; Cutaneous lymphomas; Extracorporeal photopheresis

Indexed keywords

ALPHA INTERFERON; BEXAROTENE; DENILEUKIN DIFTITOX; PENTOSTATIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CUTANEOUS T CELL LYMPHOMA; EXTRACORPOREAL PHOTOPHERESIS; FEMALE; FOLLOW UP; HUMAN; MALE; PROGRESSION FREE SURVIVAL; PUVA; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOLOGIC FACTORS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; PHOTOPHERESIS; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 84858292676     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2011.10.029     Document Type: Article

References (25)

1. Prince H.M., Whittaker S., Hoppe R.T. How I treat mycosis fungoides and Sézary syndrome. Blood 2009, 114:4337-4353.
2. Edelson R., Berger C., Gasparro F., Jegasothy B., Heald P., Wintroub B., et al. Treatment of cutaneous Tcell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med 1987, 316:297-303.
3. Knobler R., Barr M.L., Couriel D.R., Ferrara J.L., French L.E., Jaksch P., et al. Extracorporeal photopheresis: past, present, and future. J Am Acad Dermatol 2009, 61:652-665.
4. Oliven A., Shechter Y. Extracorporeal photopheresis: a review. Blood Rev 2001, 15:103-108.
5. Scarisbrick J.J., Taylor P., Holtick U., Makar Y., Douglas K., Berlin G., et al. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. Br J Dermatol 2008, 158:659-678.
6. Miller J.D., Kirkland E.B., Domingo D.S., Scull H., Jekutis B., Dallas M., et al. Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma. Photodermatol Photoimmunol Photomed 2007, 23:163-171.
7. Gottlieb S.L., Wolfe J.T., Fox F.E., DeNardo B.J., Macey W.H., Bromley P.G., et al. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution. J Am Acad Dermatol 1996, 35:946-957.
8. Talpur R., Ward S., Apisarnthanarax N., Breuer-Mcham J., Duvic M. Optimizing bexarotene therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 2002, 47:672-684.
9. Duvic M., Chiao N., Talpur R. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J Cutan Med Surg 2003, 7:3-7.
10. Tsirigotis P., Pappa V., Papageorgiou S., Kapsimali V., Giannopoulou V., Kaitsa I., et al. Extracorporeal photopheresis in combination with bexarotene in the treatment of mycosis fungoides and Sézary syndrome. Br J Dermatol 2007, 156:1379-1381.
11. Olsen E., Vonderheid E., Pimpinelli N., Willemze R., Kim Y., Knobler R., et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007, 110:1713-1722.
12. McKenna K.E., Whittaker S., Rhodes L.E., Taylor P., Lloyd J., Ibbotson S., et al. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the UK Skin Lymphoma Group. Br J Dermatol 2006, 154:7-20.
13. Duvic M., Hester J.P., Lemak N.A. Photopheresis therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1996, 35:573-579.
14. Querfeld C., Rosen S.T., Guitart J., Kuzel T.M. The spectrum of cutaneous T-cell lymphomas: new insights into biology and therapy. Curr Opin Hematol 2005, 12:273-278.
15. Heshmati F. Mechanisms of action of extracorporeal photochemotherapy. Transfus Apher Sci 2003, 29:61-70.
16. Berger C.L., Longley J., Hanlon D., Girardi M., Edelson R. The clonotypic T cell receptor is a source of tumor-associated antigens in cutaneous T cell lymphoma. Ann NY Acad Sci 2001, 941:106-122.
17. Bladon J., Taylor P.C. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients. Br J Haematol 1999, 107:707-711.
18. Di Renzo M., Rubegni P., De Aloe G., Paulesu L., Pasqui A.L., Andreassi L., et al. Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma. Immunology 1997, 92:99-103.
19. Rao V., Saunes M., Jørstad S., Moen T. Cutaneous T cell lymphoma and graft-versus-host disease: a comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+ regulatory. T cells Clin Immunol 2009, 133:303-313.
20. Scarisbrick J. Extracorporeal photopheresis: what is it and when should it be used?. Clin Exp Dermatol 2009, 34:757-760.
21. Rao V., Ryggen K., Aarhaug M., Dai H.Y., Jørstad S., Moen T. Extracorporeal photochemotherapy in patients with cutaneous T-cell lymphoma: is clinical response predictable?. J Eur Acad Dermatol Venereol 2006, 20:1100-1107.
22. Geskin L. ECP versus PUVA for the Treatment of Cutaneous T-Cell Lymphoma. Skin Therapy Lett 2007, 12:1-4.
23. Fraser-Andrews E., Woolford A.J., Russell-Jones R., Seed P.T., Whittaker S.J. Detection of a peripheral blood T cell clone is an independent prognostic marker in Sezary syndrome. J Inv Dermatol 2000, 144:117-121.
24. Scarisbrick J.J., Whittaker S., Evans A.V., Fraser-Andrews E.A., Child F.J., Dean A., et al. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma. Blood 2001, 97:624-630.
25. Vega F., Luthra R., Medeiros L.J., Dunmire V., Lee S.J., Duvic M., et al. Clonal heterogeneity in mycosis fungoides and its relationship to clinical course. Blood 2002, 100:3369-3373.